Skip Nav Destination
Close Modal
Update search
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
NARROW
Format
Article Type
Date
Availability
1-7 of 7
Keywords: myeloperoxidase
Close
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Sort by
Articles
Carbamylation of LDL and its relationship with myeloperoxidase in Type 2 diabetes mellitus
Available to Purchase
Journal:
Clinical Science
Clin Sci (Lond) (2014) 126 (2): 175–181.
Published: 23 September 2013
...Sammy W. M. Shiu; Su-Mei Xiao; Ying Wong; Wing-Sun Chow; Karen S. L. Lam; Kathryn C.B. Tan LDL (low-density lipoprotein) is subjected to pro-atherogenic modifications in the circulation. A novel uraemia-independent mechanism of carbamylation of lipoproteins mediated by MPO (myeloperoxidase) has...
Articles
Journal:
Clinical Science
Clin Sci (Lond) (2011) 120 (6): 231–238.
Published: 03 December 2010
... is properly cited. myeloperoxidase myocardial infarction neutrophil peptide prognosis proteinase 3 Atherosclerosis is associated with inflammatory changes in the blood vessel wall [ 1 ], including macrophage and lymphocyte infiltration. There is an association between neutrophil count...
Articles
Myeloperoxidase-mediated lipoprotein carbamylation as a mechanistic pathway for atherosclerotic vascular disease
Available to Purchase
Journal:
Clinical Science
Clin Sci (Lond) (2009) 116 (9): 681–695.
Published: 02 April 2009
...Sanjeev Sirpal There is an emerging and significant body of research that suggests that MPO (myeloperoxidase) may be a critical mediator in dysfunctional lipoprotein formation and, hence, atherogenic initiation and progression. MPO is a haem peroxidase found in leucocytes and is abundant...
Articles
Biliary lactoferrin concentrations are increased in active inflammatory bowel disease: a factor in the pathogenesis of primary sclerosing cholangitis?
Available to Purchase
Journal:
Clinical Science
Clin Sci (Lond) (1998) 95 (5): 637–644.
Published: 01 November 1998
... with ulcerative colitis and 21 patients with Crohn's disease. Biliary lactoferrin and myeloperoxidase concentrations were quantified by ELISA. 3. In active ulcerative colitis, the mean lactoferrin concentration in gall bladder bile of 2.8±0.40 ;mg/l was higher than that seen after colectomy (1.2±0.11 ;mg/l; P...
Articles
Mild Endotoxaemia and the Inflammatory Response Induced by a Marathon Race
Available to Purchase
Journal:
Clinical Science
Clin Sci (Lond) (1997) 92 (4): 415–422.
Published: 01 April 1997
... of the inflammatory response to exercise were measured: polymorphonuclear myeloperoxidase (MPO), anaphylatoxin C5a (C5a), tumour necrosis factor-α (TNF-α) and interleukin-6 (IL-6). Plasma endotoxin was measured by a sensitive and rapid chromogenic Limulus assay. All inflammatory markers were significantly increased...
Articles
Differential Excretion of Leucocyte Granule Components in Inflammatory Bowel Disease: Implications for Pathogenesis
Available to PurchaseA. D. Dwarakanath, I. A. Finnie, C. M. Beesley, G. M. O'Dowd, J. Nash, H. H. Tsai, N. Parker, Jonathan M. Rhodes
Journal:
Clinical Science
Clin Sci (Lond) (1997) 92 (3): 307–313.
Published: 01 March 1997
...A. D. Dwarakanath; I. A. Finnie; C. M. Beesley; G. M. O'Dowd; J. Nash; H. H. Tsai; N. Parker; Jonathan M. Rhodes 1. Faecal excretion of the leucocyte primary granule component, myeloperoxidase, and of the secondary granule component, lactoferrín, were compared in inflammatory bowel disease...
Articles
Interactions among stimulated human polymorphonuclear leucocytes, released elastase and bronchial antileucoprotease
Available to Purchase
Journal:
Clinical Science
Clin Sci (Lond) (1988) 75 (1): 53–62.
Published: 01 July 1988
... in a rapid loss of anti-elastase activity which paralleled that of the antitrypsin activity, suggesting that both inhibitor activities are represented by the same active site. 3. The myeloperoxidase-oxidizing system was found to be responsible for the inactivation of ALP. 4. The oxidized inhibitor was unable...